Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ELUT

Elutia (ELUT)

Elutia Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ELUT
DateTimeSourceHeadlineSymbolCompany
15/11/202409:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELUTElutia Inc
15/11/202408:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
15/11/202408:05GlobeNewswire Inc.Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025NASDAQ:ELUTElutia Inc
14/11/202408:05GlobeNewswire Inc.Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:ELUTElutia Inc
30/10/202407:05GlobeNewswire Inc.Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024NASDAQ:ELUTElutia Inc
24/10/202407:05GlobeNewswire Inc.Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30NASDAQ:ELUTElutia Inc
15/10/202421:59Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ELUTElutia Inc
04/10/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
18/09/202422:00GlobeNewswire Inc.Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable DevicesNASDAQ:ELUTElutia Inc
07/09/202406:23GlobeNewswire Inc.Elutia Celebrates First YearNASDAQ:ELUTElutia Inc
06/09/202406:05GlobeNewswire Inc.Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and NeurostimulatorsNASDAQ:ELUTElutia Inc
04/09/202406:05GlobeNewswire Inc.Elutia to Participate in Upcoming Investor ConferencesNASDAQ:ELUTElutia Inc
13/08/202423:22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELUTElutia Inc
13/08/202423:22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELUTElutia Inc
08/08/202406:05GlobeNewswire Inc.Elutia Announces Second Quarter 2024 ResultsNASDAQ:ELUTElutia Inc
08/08/202406:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
02/08/202406:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
02/08/202406:05GlobeNewswire Inc.Elutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross ProceedsNASDAQ:ELUTElutia Inc
01/08/202406:05GlobeNewswire Inc.Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of OperationsNASDAQ:ELUTElutia Inc
31/07/202406:05GlobeNewswire Inc.Elutia to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024NASDAQ:ELUTElutia Inc
12/07/202406:05GlobeNewswire Inc.Elutia to Present at the Emerging Growth Conference on Thursday, July 18NASDAQ:ELUTElutia Inc
19/06/202406:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
17/06/202422:30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ELUTElutia Inc
17/06/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
17/06/202422:01GlobeNewswire Inc.Elutia Announces $13.26 Million Registered Direct OfferingNASDAQ:ELUTElutia Inc
17/06/202422:00GlobeNewswire Inc.Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and DefibrillatorsNASDAQ:ELUTElutia Inc
11/06/202407:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
11/06/202407:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
11/06/202407:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
08/06/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
 Showing the most relevant articles for your search:NASDAQ:ELUT